RHKd logo

RHÖN-KLINIKUM BATS-CHIXE:RHKd Stock Report

Last Price

€10.15

Market Cap

€743.0m

7D

0%

1Y

n/a

Updated

20 Mar, 2024

Data

Company Financials

RHÖN-KLINIKUM Aktiengesellschaft

BATS-CHIXE:RHKd Stock Report

Market Cap: €743.0m

RHKd Stock Overview

Offers in-patient, semi-patient, and outpatient healthcare services in Germany. More details

RHKd fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance4/6
Financial Health4/6
Dividends1/6

My Notes

Capture your thoughts, links and company narrative

RHÖN-KLINIKUM Aktiengesellschaft Competitors

Price History & Performance

Summary of share price highs, lows and changes for RHÖN-KLINIKUM
Historical stock prices
Current Share Price€10.15
52 Week High€0
52 Week Low€0
Beta-0.014
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Change-59.63%
Change since IPO-52.19%

Recent News & Updates

Recent updates

Shareholder Returns

RHKdGB HealthcareGB Market
7D0%-2.9%-1.9%
1Yn/a-26.8%2.6%

Return vs Industry: Insufficient data to determine how RHKd performed against the UK Healthcare industry.

Return vs Market: Insufficient data to determine how RHKd performed against the UK Market.

Price Volatility

Is RHKd's price volatile compared to industry and market?
RHKd volatility
RHKd Average Weekly Movementn/a
Healthcare Industry Average Movement5.0%
Market Average Movement4.8%
10% most volatile stocks in GB Market10.7%
10% least volatile stocks in GB Market2.6%

Stable Share Price: RHKd has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine RHKd's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
197318,158Tobias Kaltenbachwww.rhoen-klinikum-ag.com

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.

RHÖN-KLINIKUM Aktiengesellschaft Fundamentals Summary

How do RHÖN-KLINIKUM's earnings and revenue compare to its market cap?
RHKd fundamental statistics
Market cap€743.02m
Earnings (TTM)€31.92m
Revenue (TTM)€1.71b

23.3x

P/E Ratio

0.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RHKd income statement (TTM)
Revenue€1.71b
Cost of Revenue€1.50b
Gross Profit€202.27m
Other Expenses€170.35m
Earnings€31.92m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Mar 28, 2024

Earnings per share (EPS)0.48
Gross Margin11.85%
Net Profit Margin1.87%
Debt/Equity Ratio11.9%

How did RHKd perform over the long term?

See historical performance and comparison

Dividends

1.4%

Current Dividend Yield

31%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/03/20 10:11
End of Day Share Price 2023/12/22 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

RHÖN-KLINIKUM Aktiengesellschaft is covered by 36 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Eileen RyanAlphaValue
Gerhard SchwarzBaader Helvea Equity Research
Thomas JonesBerenberg